FridayMar 16, 2018 9:58 am

CannabisNewsBreaks – PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) Incorporates Australian Subsidiary

Health sciences company PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) this morning announced the incorporation of its first Australian wholly owned subsidiary, PreveCeutical (Australia) Pty Ltd. Per the update, the company’s decision to incorporate a subsidiary in Australia was influenced by the nation’s strong foundation of academic and clinical research, as well as the government’s commitment to supporting innovation through a range of programs and incentives. “Establishing a business presence in Australia will allow PreveCeutical to better access expertise and partnerships for its drug development programs,” Dr. Maher Khaled, PreveCeutical’s director of international operations, stated in the news…

Continue Reading

FridayMar 16, 2018 9:29 am

CannabisNewsBreaks – ABcann Global Corp. (TSX.V: ABCN) (OTCQB: ABCCF) Announces Resignation of Ken Clement

ABcann Global Corp. (TSX.V: ABCN) (OTCQB: ABCCF), a pharmaceutical-grade cannabis company with production and sales licenses from Health Canada, this morning announced that its founder and director, Ken Clement, has resigned from its board of directors. “On behalf of the Board, we thank Ken for his vision in starting the company and growing it from a start-up organization into a well-funded publicly-traded licensed producer with a bright future,” Paul Lucas, chairman of ABcann, stated in the news release. “We wish Ken well in his future endeavours.” To view the full press release, visit http://cnw.fm/riDc3 About ABcann Global Corp. ABcann holds…

Continue Reading

WednesdayMar 14, 2018 11:44 am

CannabisNewsBreaks – Liberty Leaf Holdings Ltd. (CSE: LIB) (OTCQB: LIBFF) (FSE: HN3P) and Blox Labs, Inc. (CSE: BLOX) (OTC: BLLXF) Complete Preliminary Input and Analysis in Phase One Development of cannaBLOX

Liberty Leaf Holdings Ltd. (CSE: LIB) (OTCQB: LIBFF) (FSE: HN3P) is working in partnership with Blox Labs, Inc. (CSE: BLOX) (OTC: BLLXF) to create cannaBLOX, a blockchain-based software smart contract platform for the legalized cannabis industry. An article discussing the joint development reads: “Liberty Leaf Holdings Ltd. (CSE: LIB) (OTCQB: LIBFF) (FSE: HN3P) and Blox Labs, Inc. (CSE: BLOX) (OTC: BLLXF) have announced progress on their joint development of phase one of cannaBLOX, the blockchain-based smart contract platform for the legalized cannabis industry (http://cnw.fm/4DmPU). … Blox Labs is working to complete its white paper on cannaBLOX, and a satellite development…

Continue Reading

TuesdayMar 13, 2018 10:57 am

CannabisNewsBreaks – Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Reports Positive Results from Skin Absorption Study

Lexaria Bioscience (CSE: LXX) (OTCQB: LXRP) this morning said that it has completed the first study evaluating DehydraTECH™ used in a topical cream formulation for absorption of cannabidiol ("CBD") through human skin. Compared to control formulations, significant increases in the speed and quantity of CBD absorption through skin were proven in the study. Several factors were measured during the study at multiple testing intervals over a 48-hour duration, including the time required to detect CBD skin penetration and quantity as well as the peak amounts of CBD absorbed.  Lexaria's DehydraTECH-enabled topical formulation without the addition of either of the commercial…

Continue Reading

TuesdayMar 13, 2018 9:55 am

CannabisNewsBreaks – PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) Announces Grant of Australian Cannabis Importation Permits

Health sciences company PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H), alongside Aurora Cannabis Inc. (TSX: ACB) (OTCQB: ACBFF) (FSE: 21P), this morning announced the grant of three permits by the Australian government’s Department of Health for the importation of cannabis into the country for research purposes. Per the news release, cannabis related to these permits will be shipped from Canada by Aurora for use in PreveCeutical’s soluble gel (“Sol-gel”) drug delivery research program, which is being conducted by the company’s research partner, UniQuest Pty Inc., and led by PreveCeutical’s chief research officer, Dr. Harendra Parekh. “We are extremely…

Continue Reading

MondayMar 12, 2018 9:29 am

CannabisNewsBreaks – Pivot Pharmaceuticals Inc. (CSE: PVOT) (OTCQB: PVOTF) Preparing to File Dealer’s License Application for Agro-Biotech Inc.

Vancouver-based biopharmaceutical company Pivot Pharmaceuticals Inc. (CSE: PVOT) (OTCQB: PVOTF) this morning announced that it has retained Cannabis Compliance Inc. (“CCI”) in order to submit an application, on behalf of Agro-Biotech Inc., to Health Canada for a dealer’s license under the Controlled Drugs and Substances Act and the Narcotic Control Regulations enacted thereunder. This morning’s update comes on the heels of a February 22 announcement of Pivot’s entry into a letter of intent for the proposed acquisition of Agro-Biotech. “The addition of a Dealer's License for the Agro-Biotech facility will allow the Company to exercise complete control of our finished…

Continue Reading

FridayMar 09, 2018 3:11 pm

CannabisNewsBreaks – Liberty Leaf Holdings Ltd. (CSE: LIB) (OTCQB: LIBFF) (FSE: HN3P) Grows in Cannabis Industry through Strategic Investments

Liberty Leaf Holdings Ltd. (CSE: LIB) (OTCQB: LIBFF) (FSE: HN3P) is a vertically-integrated cannabis company with strategic investments focusing on proven, revenue-generating businesses. An article discussing the company reads: “Liberty Leaf Holdings Ltd. (CSE: LIB) (OTCQB: LIBFF) (FSE: HN3P) is a publicly traded Canadian-based company with strategic investments in businesses that are established, revenue- producing players in the medicinal and recreational cannabis market. Liberty Leaf’s focus is to build and support a diversified portfolio of cannabis-sector businesses, including those involved in the cultivation and processing of legal medicinal and recreational cannabis, value-added CBD/THC pet products, and supply-chain products for this…

Continue Reading

FridayMar 09, 2018 3:05 pm

CannabisNewsBreaks – PreveCeutical Medical Inc.’s (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) Proprietary Sol-gel Formulations May Significantly Improve Bioavailability

Health sciences company PreveCeutical Medical (PRVCF) is engineering a unique Sol-gel CBD-based technology delivery platform to provide direct, controlled pharmacological drug release. This technology could provide a clinical benefit for patients seeking relief for multiple medical indications including pain, inflammation, seizures and neurological disorders. An article discussing the company’s proprietary technology reads: “PreveCeutical’s proprietary Sol-gel formulations begin as a liquid that is administrated into the nose, which then forms a gel as it is warmed in the nasal cavity where it can then be absorbed. This effectively bypasses the stomach and intestines – eliminating first pass metabolism – and may…

Continue Reading

ThursdayMar 08, 2018 3:42 pm

CannabisNewsBreaks – Lexaria Bioscience Corp.’s (CSE: LXX) (OTCQX: LXRP) Innovative Technology is Well-suited in the Cannabis Industry

Lexaria Bioscience (CSE: LXX) (OTCQB: LXRP) has recently developed an oral digestion technology, DehydraTECH™, which is a complementary layer that works with other R&D efforts regarding cannaboids. An article discussing the company reads: “DehydraTECH allows for faster delivery time, lower dosages and shorter treatment regimens. Oral ingestion of the client drug eliminates unhealthy practices of inhalation dosing. It improves the absorption rate, by as much as five to 10 times, of non-steroid anti-inflammatory drugs (NSAIDs), vitamins, cannabinoids and even nicotine. Delivery time, the time it takes from ingestion to payload molecules reaching the bloodstream, is reduced from the 60-90 minutes…

Continue Reading

ThursdayMar 08, 2018 9:56 am

CannabisNewsBreaks – ABcann Global Corp. (TSX.V: ABCN) (OTCQB: ABCCF) Engages VIRTUE to Serve as Agency of Record

ABcann Global (TSX.V: ABCN) (OTCQB: ABCCF) this morning announced that it has retained VIRTUE as its agency-of-record. VIRTUE, a creative agency powered by VICE Media, will develop a full rebrand and create sub-brands targeting the medical and adult-use cannabis markets. The agency will also assist the company with an integrated launch strategy for its new brands. “VIRTUE is an award-winning marketing agency with an unwavering commitment to bold ideas. They are the ideal partners to help us to transform the company’s brand and convey the purpose behind our current medical and upcoming adult-use cannabis businesses,” ABcann chief marketing officer Sung…

Continue Reading

CanadianCannabisWire Currently Accepts

Bitcoin

Bitcoin

Bitcoin Cash

Bitcoin Cash

Doge Coin

Dogecoin

Ethereum

Ethereum

Litecoin

Litecoin

USD Coin

USD Coin

Contact us: 905.674.5977